No Data
No Data
No Data
No Data
No Data
CervoMed Updates Stakeholders on Clinical and Financial Status
TipRanksApr 23 08:13 ET
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Canaccord
BenzingaApr 8 08:00 ET
CervoMed Is Maintained at Buy by Canaccord Genuity
CervoMed Is Maintained at Buy by Canaccord Genuity
Dow JonesApr 8 07:48 ET
Canaccord Genuity Maintains Buy on CervoMed, Raises Price Target to $65
Canaccord Genuity analyst Sumant Kulkarni maintains CervoMed (NASDAQ:CRVO) with a Buy and raises the price target from $50 to $65.
BenzingaApr 8 07:37 ET
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), CervoMed (CRVO) and Teladoc (TDOC)
TipRanksApr 8 07:30 ET
CervoMed Shares Operational and Financial Insights Online
TipRanksApr 4 07:12 ET
Chasing_Freedom : fr dude crazy af
imLearning : will it run one more time today
Cold HeartOP imLearning: Merger is big news
imLearning Cold HeartOP: was it? I got in at 9+, saw it tanked ah, wonder if I should just take a loss pre-market before it dips even lower than $4-$5
No Data
No Data